S
Shiri Navon-Venezia
Researcher at Ariel University
Publications - 122
Citations - 10305
Shiri Navon-Venezia is an academic researcher from Ariel University. The author has contributed to research in topics: Klebsiella pneumoniae & Plasmid. The author has an hindex of 50, co-authored 121 publications receiving 9310 citations. Previous affiliations of Shiri Navon-Venezia include Tel Aviv University & Israel Ministry of Health.
Papers
More filters
Journal ArticleDOI
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
TL;DR: The data highlight the complex evolution of MDR and XDR K. pneumoniae, involving transfer and spread of ARGs, and epidemic plasmids in highly disseminating successful clones, and a need for future genomic and translational studies to decipher specific targets in HiR clones to design targeted prevention and treatment.
Journal ArticleDOI
Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact
TL;DR: An epidemiologic evaluation and molecular typing using pulsed-field gel electrophoresis for 82 patients with MDR P. aeruginosa found that survivors functioned more poorly at discharge than the controls, and more of the survivors were discharged to rehabilitation centers or chronic care facilities.
Journal ArticleDOI
Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258
Brandon Kitchel,J. Kamile Rasheed,Jean B. Patel,Arjun Srinivasan,Shiri Navon-Venezia,Yehuda Carmeli,Alma Brolund,Christian G. Giske +7 more
TL;DR: Restriction analysis of plasmid DNA prepared from transformants revealed a diversity of band patterns, suggesting the presence of different plasmids harboring the blaKPC gene, even among isolates of the same ST.
Journal ArticleDOI
Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality
Mitchell J. Schwaber,Shiri Klarfeld-Lidji,Shiri Navon-Venezia,David A. Schwartz,Azita Leavitt,Yehuda Carmeli +5 more
TL;DR: CRKP affects patients with poor functional status, an ICU stay, and antibiotic exposure and is an independent predictor of death.
Journal ArticleDOI
Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing Enterobacteriaceae
Mitchell J. Schwaber,Shiri Navon-Venezia,Keith S. Kaye,Ronen Ben-Ami,David A. Schwartz,Yehuda Carmeli +5 more
TL;DR: ESBL production was associated with severe adverse outcomes, including higher overall and infection-related mortality, increased LOS, DAT, discharge to chronic care, and higher costs.